Blunted Post-COVID-19 Humoral Immunity in Patients With CNS Demyelinating Disorders on Anti-CD20 Treatments

With unclear characteristics of post-infection and post-vaccination immunity, the multiple sclerosis community lacks evidence to guide patients on their continued coronavirus disease 2019 (COVID-19) infection risk. As disease modifying treatments all modulate the immune system, we expect their use t...

Descripción completa

Detalles Bibliográficos
Autores principales: Money, Kelli M., Baber, Ursela, Saart, Emma, Samaan, Soleil, Sloane, Jacob A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905651/
https://www.ncbi.nlm.nih.gov/pubmed/35280260
http://dx.doi.org/10.3389/fneur.2022.843081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905651/
https://www.ncbi.nlm.nih.gov/pubmed/35280260
http://dx.doi.org/10.3389/fneur.2022.843081

Ejemplares similares